Erik Norström
Corporate Officer/Principal at TECAN GROUP AG
Net worth: 825 745 $ as of 30/04/2024
Network origin in Erik Norström first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
40
| Subsidiary | Pharmaceuticals: Major | 40 |
| Public Company | Medical Specialties | 23 | |
Chalmers University of Technology
13
| College/University | Other Consumer Services | 13 |
| Extinct | Food: Specialty/Candy | 8 | |
Andrew Alliance SA
 Andrew Alliance SA Industrial MachineryProducer Manufacturing Andrew Alliance SA develops liquid handling solutions. Its product, Andrew, is a novel liquid handling robot designed for pipetting process. The firm's products include Andrew models, consumable dominos, protocol design, and enabling accessories. The company was founded by Piero Zucchelli, Giorgio Horak, and Antoine Jordan in March 2011 and is headquartered in Vernier, Switzerland.
4
| Subsidiary | Industrial Machinery | 4 |
Chr. Hansen A/S
 Chr. Hansen A/S Pharmaceuticals: OtherHealth Technology Chr. Hansen A/S engages in bioscience research that develops natural solutions for the food, nutritional, pharmaceutical and agricultural industries. It also develops and produces cultures, enzymes, probiotics and natural colors for a rich variety of foods, confectionery, beverages, dietary supplements and even animal feed. The company was founded by Christian D. A Hansen in 1874 and is headquartered in Horsholm, Denmark.
3
| Subsidiary | Pharmaceuticals: Other | 3 |
labforward GmbH
 labforward GmbH Information Technology ServicesTechnology Services labforward GmbH develops a digital laboratory notebook for scientists to organize research, create protocol templates, and collaborate and share with other scientists. The firm offers labfolder, an online platform for the documentation and analysis of experimental scientific data. The company was founded by Simon Bungers, Florian Hauer, and Mathias Schäffner in 2012 and is headquartered in Berlin, Germany.
2
| Holding Company | Information Technology Services | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Erik Norström via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Swiss Federal Institute of Technology | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Secretary Corporate Officer/Principal Human Resources Officer | |
| University of Freiburg | College/University | Corporate Officer/Principal Undergraduate Degree Graduate Degree Doctorate Degree | |
| University of Basel | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Graduate Degree | |
| BAYER AG | Pharmaceuticals: Major | Chairman Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| International Institute for Management Development | College/University | Director/Board Member Masters Business Admin Masters Business Admin | |
| Copenhagen Business School | College/University | Graduate Degree Graduate Degree Graduate Degree | |
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Miscellaneous Commercial Services | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
PIQUR Therapeutics AG
 PIQUR Therapeutics AG Pharmaceuticals: OtherHealth Technology PIQUR Therapeutics AG engages in development of anti-cancer drugs based on the inhibition. Its products include PQR309, PQR620 and PQR5xx. The company was founded by Bernd Giese, Vladimir Cmiljanovic, Andreas Emmenegger, Ralf Rosenow and Matthias Wymann in August 2011 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Other | Founder Chairman Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Public Communications Contact Corporate Officer/Principal Comptroller/Controller/Auditor | |
| University of Gothenburg | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| Freie Universität Berlin | College/University | Doctorate Degree Doctorate Degree | |
Vivet Therapeutics SAS
 Vivet Therapeutics SAS BiotechnologyHealth Technology Vivet Therapeutics SAS develops novel gene therapy treatments for inherited metabolic diseases. The firm offers its services under the categorizers of Biopharma, Biotechnology and Health Care. The company was founded by Jean-Philippe Combal, Gloria Gonzalez-Aseguinolaza and Jens Kurth on July 26, 2016 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director/Board Member | |
Roche Ventures
 Roche Ventures Investment ManagersFinance Roche Ventures is the venture investment division of the pharmaceutical company F. Hoffmann-La Roche Ltd., which is a subsidiary of Roche Holding AG (SWX:ROG). The group is headquartered in Basel with operations and affiliates worldwide, and is a world leader in pharmaceuticals and diagnostics. The firm was founded in 2002. | Investment Managers | Director of Finance/CFO Private Equity Investor | |
| REVVITY, INC. | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| The Rockefeller University | College/University | Doctorate Degree Doctorate Degree | |
| Analytical Life Science & Diagnostics Association | Director/Board Member Director/Board Member | ||
Hilti AG
 Hilti AG Metal FabricationProducer Manufacturing Hilti AG engages in the development, manufacture, and sale of construction tools and equipment. The company's product portfolio includes anchor systems, construction chemicals, cordless systems, direct fastening, drilling and demolition, firestop, diamond coring and cutting, modular support systems, measuring systems, screw fastening, façade systems, as well as accessories. It also provides system solutions, as well as software and services. The company was founded by Martin Hilti and Eugen Hilti in 1941 and is headquartered in Schaan, Liechtenstein. | Metal Fabrication | Chairman Director/Board Member | |
Leica Microsystems GmbH
 Leica Microsystems GmbH Electronic ComponentsElectronic Technology Leica Microsystems GmbH develops and manufactures high precision optical systems. Its products includes microscopes and imaging solutions, modular microscopers for needs. The company was founded in 1849 and is headquartered in Wetzlar, Germany. | Electronic Components | President Corporate Officer/Principal | |
Roche Glycart AG
 Roche Glycart AG Pharmaceuticals: MajorHealth Technology Roche Glycart AG discovers and develops drugs. It is active in the research and development of new potent antibody-based products for the treatment of unmet clinical needs such as cancer. It uses its proprietary set of technologies to endow therapeutic antibodies. The company has developed glycoengineering technology (GlycoMAb) to boost a natural mechanism of action of therapeutic antibodies developed to mediate target cell killing. The company was founded in 2000 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| STRATEC SE | Medical Specialties | Chairman Corporate Officer/Principal | |
| ADDEX THERAPEUTICS LTD | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Boston University | College/University | Graduate Degree Graduate Degree | |
| Schweizerische Management Gesellschaft | President Director/Board Member | ||
| SMITH & NEPHEW PLC | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
| SULZER LTD | Industrial Machinery | Director/Board Member Comptroller/Controller/Auditor | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| SCHWEITER TECHNOLOGIES AG | Industrial Machinery | Director/Board Member Director/Board Member | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| NESTLÉ S.A. | Food: Major Diversified | Director/Board Member Corporate Officer/Principal | |
Nutrition-Wellness Venture AG
 Nutrition-Wellness Venture AG Financial ConglomeratesFinance Part of Nestlé SA, Nutrition-Wellness Venture AG is an investment holding Swiss company. The company is based in Vevey, Switzerland. | Financial Conglomerates | Chairman Director/Board Member | |
TeGenero AG
 TeGenero AG Pharmaceuticals: MajorHealth Technology TeGenero AG discovers and develops novel therapeutics. It is a biopharmaceutical company providing services in the identification and development of effective and applicable therapeutics for the treatment of severe immunological disorders. It's first development candidate TGN1412, a SuperMAB with specificity for the T cell surface receptor CD28 is in non-clinical development. Clinical applications of SuperMAB and its derived compounds are expected to solve unmet medical needs in the fields of cancer-related immunodeficiencies such as B-cell chronic lymphocytic leukaemia and autoimmune/inflammatory diseases like rheumatoid arthritis. The company was founded in 2000 and is headquartered in Wurzburg, Germany. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| ESCP Europe Campus Paris | College/University | Undergraduate Degree Undergraduate Degree | |
| Friedrich-Alexander University of Erlangen-Nuremberg | College/University | Undergraduate Degree Doctorate Degree | |
Targimmune Therapeutics AG
 Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Founder Chairman | |
| Technical University of Denmark | College/University | Graduate Degree Graduate Degree | |
Minoryx Therapeutics SL
 Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Doctorate Degree | |
TOLREMO therapeutics AG
 TOLREMO therapeutics AG Miscellaneous Commercial ServicesCommercial Services TOLREMO therapeutics AG engages in discovering and developing therapies for treating cancer patients. The firm serves on academic research laboratories, flourishing life sciences spin-offs and cutting-edge technology platforms. The company was founded by Stefanie Flückiger-Mangual, Wilhelm Krek, Karl-Heinz Altmann, Isaac Kobrin, and Emmanuel Savioz in March 2017 and is headquartered in Zurich, Switzerland. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Vivacta Ltd.
 Vivacta Ltd. Medical SpecialtiesHealth Technology Vivacta Ltd. operates as a medical diagnostics company. It develop point of care diagnostic device and microfluidic cartridge. The company is founded in 2005 and is headquartered in Camberley, the United Kingdom. | Medical Specialties | Chairman Director/Board Member | |
| AUXILIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member |
Statistics
International
| Switzerland | 20 |
| Germany | 12 |
| United States | 8 |
| Denmark | 5 |
| France | 4 |
Sectoral
| Health Technology | 24 |
| Consumer Services | 15 |
| Commercial Services | 4 |
| Producer Manufacturing | 4 |
| Finance | 3 |
Operational
| Director/Board Member | 438 |
| Corporate Officer/Principal | 211 |
| Chairman | 159 |
| Independent Dir/Board Member | 79 |
| Chief Executive Officer | 61 |
Most connected contacts
| Insiders | |
|---|---|
| Carl Fredrik Wilhelm Bandhold | 47 |
| Rolf Classon | 47 |
| Bradley Bolzon | 41 |
| Luis Cantarell Rocamora | 35 |
| Erich Maximilian Platzer | 31 |
| Erich Hunziker | 28 |
| Jesper Brandgaard | 28 |
| Heinrich Fischer | 26 |
| Carole Nüchterlein | 26 |
| Pamela Kirby | 22 |
| Jacob Key | 22 |
| Richard T. Laube | 21 |
| Daniel Marshak | 21 |
| Gérard Vaillant | 20 |
| Heino von Prondzynski | 19 |
- Stock Market
- Insiders
- Erik Norström
- Company connections
